The follicular-phase depot gnrh agonist protocol results in a higher live birth rate without discernible differences in luteal function and child health versus the daily mid-luteal gnrh agonist protocol: a single-centre, retrospective, propensity score matched cohort study

HIGHLIGHTS

• who: Ying Zhang from the Reproductive Medicine Center, Renmin Hospital, Hubei University of Medicine, Shiyan, People`s Republic of China have published the research work: The follicular-phase depot GnRH agonist protocol results in a higher live birth rate without discernible differences in luteal function and child health versus the daily mid-luteal GnRH agonist protocol: a single-centre, retrospective, propensity score matched cohort study, in the Journal: (JOURNAL) of 10/09/2022
• what: Given that full-dose GnRH-a may excessively inhibit the pituitary gland and ovary, some of the early studies focused on . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.